The Hawaiʻi Hepatitis B Mortality and Liver Cancer Incidence and Mortality Report identifies the state’s current and historical trends in mortality for hepatitis B and incidence and mortality for liver cancer from 2000-2020. The findings of this report demonstrate the importance of hepatitis elimination, in alignment with Hawaiʻi’s Hep Free 2030 Plan. This first-of-its-kind report was published in January 2023 by the Hawaiʻi Department of Health and written by experts in epidemiology, data analytics, and viral hepatitis public health programming.
Below are some highlights:
- Hawaiʻi has one of the highest hepatitis B-associated death rates nationwide. In 2019, the rate for Hawaiʻi was almost 3 times the national rate (1.17 compared to 0.42 per 100,000) (pg. 9)
- Between 2018 and 2020, Asian and Pacific Islander residents accounted for disproportionately higher rates of Hepatitis-B associated deaths compared to all Hawaiʻi residents (1.22 compared to 0.99 per 100,000) (pg. 14).
- In 2020, the liver and intrahepatic bile duct cancer-associated mortality rate in Hawaiʻi was 1.3 times higher than the national average (9.41 compared to 7.35 per 100,000) (pg. 22)
View the report and accompanying infographic here.